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Brief	description	of	research	area:	
Cobras	 (Naja	 spp.)	 are	 some	of	 the	most	 venomous	 and	 dangerous	 snakes	worldwide,	 responsible	 for	 high	
mortality	 and	 morbidity.	 The	 most	 toxic	 components	 of	 cobra	 venoms	 are	 cobratoxins,	 which	 target	 the	
nicotinic	 acetylcholine	 receptors	 (nAChRs)	 responsible	 for	neuromuscular	 transmission.	 Inhibition	of	nAChRs	
may	 lead	to	respiratory	arrest	with	death	as	a	result	within	3-12	hr	after	a	bite	 from	a	cobra.	Early	parental	
administration	of	appropriate	antivenom	is	the	cornerstone	of	life	saving	snakebite	therapy.	However,	current	
antivenoms	 are	 still	 produced	 by	 animal	 immunization,	which	 is	 a	 laborious	 and	 expensive	 process	 yielding	
highly	 immunogenic	 antivenoms	 due	 to	 the	 heterologous	 nature	 of	 equine	 antibodies	 in	 the	 antivenom.	 In	
contrast,	 novel	 antivenom	 based	 on	 synthetic	 peptides	 may	 offer	 an	 alternative	 solution,	 which	 is	 less	
expensive	and	cause	less	side	effects.		
	
What	we	know:	
A	peptide-based	antitoxin	lead	was	previously	discovered	in	our	lab	through	phage	display	selection.	The	lead	
binds	 to	 α-cobratoxin	 in	 ITC	 experiments	 and	 is	 able	 to	 inhibit	 α-cobratoxin	 binding	 to	 the	 nAChR	 in	 TEVC	
experiments.		
	 	
What	we	need:	
Currently,	 we	 are	 working	 in	 an	 approach	 for	 optimizing	 the	 peptide	 lead	 by	 designing	 and	 characterizing	
improved	 analogues.	 The	 poster	 will	 include	 the	 methodology	 and	 results	 of	 optimized	 peptide	 leads	 to	
include	in	promising	peptide-based	antitoxins.	
	
This	may	pave	the	way	 for	 treating	 the	clinical	manifestations	of	neurotoxic	envenomings	caused	by	 long	α-
neurotoxins,	thus	providing	protection	against	many	cobra	species.	
	
	
